| Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications W Liu, P Stachura, HC Xu, N Umesh Ganesh, F Cox, R Wang, KS Lang, ... Journal of Experimental & Clinical Cancer Research 39, 1-16, 2020 | 24 | 2020 |
| Senescent Tumor CD8+ T Cells: Mechanisms of Induction and Challenges to Immunotherapy W Liu, P Stachura, HC Xu, S Bhatia, A Borkhardt, PA Lang, AA Pandyra Cancers 12 (10), 2828, 2020 | 19 | 2020 |
| Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death J Longo, AA Pandyra, P Stachura, MD Minden, AD Schimmer, LZ Penn Molecular oncology 14 (10), 2533-2545, 2020 | 18 | 2020 |
| BAFF attenuates immunosuppressive monocytes in the melanoma tumor microenvironment W Liu, P Stachura, HC Xu, R Váraljai, P Shinde, NU Ganesh, M Mack, ... Cancer research 82 (2), 264-277, 2022 | 15 | 2022 |
| Deep transfer learning approach for automatic recognition of drug toxicity and inhibition of SARS-CoV-2 J Werner, RM Kronberg, P Stachura, PN Ostermann, L Müller, H Schaal, ... Viruses 13 (4), 610, 2021 | 11 | 2021 |
| Arenaviruses: Old viruses present new solutions for cancer therapy P Stachura, O Stencel, Z Lu, A Borkhardt, AA Pandyra Frontiers in Immunology 14, 1110522, 2023 | 9 | 2023 |
| The role of ADAM17 during liver damage M Al-Salihi, A Bornikoel, Y Zhuang, P Stachura, J Scheller, KS Lang, ... Biological Chemistry 402 (9), 1115-1128, 2021 | 6 | 2021 |
| Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma D Picard, J Felsberg, M Langini, P Stachura, N Qin, J Macas, Y Reiss, ... Acta neuropathologica 146 (4), 551-564, 2023 | 4 | 2023 |
| Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumors P Stachura, W Liu, HC Xu, A Wlodarczyk, O Stencel, P Pandey, M Vogt, ... Molecular Cancer 22 (1), 136, 2023 | 1 | 2023 |
| Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia F Fischer, J Schliehe-Diecks, JW Tu, T Gangnus, YL Ho, M Hebeis, ... Journal of Medicinal Chemistry 67 (23), 21223-21250, 2024 | | 2024 |
| Immune Training Enhances Anti-Viral Responses and Improves Outcomes in Pax5-/+ Mice Susceptible to Chronic Infection Z Lu, O Stencel, W Liu, E Vasileiou, HC Xu, P Pandey, P Stachura, A Elwy, ... Blood 144 (Supplement 1), 1160-1160, 2024 | | 2024 |
| A brain organoid/ALL coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALL P Gebing, S Loizou, S Hänsch, J Schliehe-Diecks, L Spory, P Stachura, ... Blood advances 8 (19), 4997-5011, 2024 | | 2024 |
| CNS Invasion of TCF3:: PBX1+ Leukemia Cells Requires Upregulation of AP-1 Signaling As Revealed By Brain Organoid Model P Gebing, S Loizou, S Hänsch, J Schliehe-Diecks, L Spory, P Stachura, ... Blood 142, 1407, 2023 | | 2023 |
| 1403-C 5-Nonyloxytryptamine reveals novel approach for MHC-I upregulation in tumors P Stachura, W Liu, H Xu, A Wlodarczyk, O Stencel, P Pandey, M Vogt, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 2), 2023 | | 2023 |
| P345: AN IMMUNE SCREEN IDENTIFIES 5-NONLOXYTRYPTAMINE AS A NOVEL ANTI-CANCER AGENT CAPABLE OF IMPROVING ANTI-TUMOR IMMUNITY IN COMBINATION WITH ANTI-PD1 THERAPY P Stachura, W Liu, A Wlodarczyk, C Xu, S Bhatia, PA Lang, A Borkhardt, ... HemaSphere 6, 245-246, 2022 | | 2022 |
| A gut instinct for childhood leukemia prevention: microbiome-targeting recommendations aimed at parents and caregivers E Kameri, VH Jepsen, P Stachura, N Rüchel, R Bhave, L BENITEZ, ... Frontiers in Public Health 12, 1445113, 0 | | |
